Archives

Goodes Prize Recipient Dr. Jeff Cummings’ 2026 Alzheimer’s Drug Pipeline Report Signals New Era of Biology-Driven Approaches

B Findings validate the Alzheimer’s Drug Discovery Foundation’s long-standing leadership in advancing strategies that target the full pathobiology of the disease NEW YORK, May 5,… Login to continue reading Login…

Read MoreGoodes Prize Recipient Dr. Jeff Cummings’ 2026 Alzheimer’s Drug Pipeline Report Signals New Era of Biology-Driven Approaches